Halozyme appoints new president, CEO
The company has promoted Michael Shepard as the chief scientific officer after having joined the company as vice president of discovery research. Halozyme president and CEO Gregory Frost
The US Food and Drug Administration (FDA) has granted breakthrough therapy designation to Eli Lilly and Company’s (Lilly) olomorasib as a potential treatment for adults with advanced pancreatic cancer who have already received at least one prior systemic therapy.